ANVS
Annovis Bio, Inc. · Healthcare
Insiders bought $1.6M net in the last 90 days ·0 sellers, 1 buyer· latest Form 4 filed May 22, 2026
Insider Buying
$4.3M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Latest filing
May 22, 2026
Hoffman Michael B
Annovis Bio, Inc. (ANVS) has 10 SEC Form 4 filings (20 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: May 22, 2026.
Inside the rolling window, 2 insiders at Annovis Bio, Inc. reported 8 open-market purchases totaling $4.3M and no open-market sales. The most active filer is Director Hoffman Michael B with 7 filings. Insiders have net bought $2.0M over the trailing 6 months. The largest single insider purchase in this window was $1.5M by Director Hoffman Michael B on Apr 2, 2026. The most recent open-market filing is a purchase of 76,344 shares by Director Hoffman Michael B, dated May 20, 2026, worth $143K.
- Industry:Biotechnology
- CEO:Maria L. Maccecchini
- Employees:7
- HQ:Malvern, PA, US
- IPO:2020-01-29
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Director | Purchase | 76,344 | $143K | May 22 | -19.3% | SEC ↗ | |
Hoffman Michael BFirst in 4 months | Director | Purchase | 713,800 | $1.5M | Apr 3 | -23.4% | SEC ↗ |
| Director | Purchase | 45,000 | $194K | Dec 8 | -58.1% | SEC ↗ | |
| Director | Purchase | 39,200 | $160K | Nov 25 | -62.7% | SEC ↗ | |
| Director | Purchase | 20,000 | $70K | Nov 21 | — | SEC ↗ | |
| Director | Purchase | 15,000 | $32K | Nov 18 | — | SEC ↗ | |
Maccecchini Maria-LuisaFirst filing | President & CEO | Purchase | 97,561 | $200K | Nov 12 | — | SEC ↗ |
Hoffman Michael BFirst filing | Director | Purchase | 975,610 | $2.0M | Nov 12 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does ANVS have?
Annovis Bio, Inc. (ANVS) has 10 SEC Form 4 filings (20 transaction rows) in the rolling 365-day window, disclosed by 2 distinct insiders. Most recent filing: May 22, 2026.
When was the most recent SEC Form 4 filing for ANVS?
The most recent Form 4 filing for ANVS on Tracefour is dated May 22, 2026.
Who is the most active insider at ANVS?
The most active SEC Form 4 filer at ANVS in the rolling window is Director Hoffman Michael B, with 7 filings.
What is the net insider flow at ANVS over the last 6 months?
Over the trailing 180 days, insiders at ANVS have net bought $2.0M based on SEC Form 4 disclosures.
What was the largest insider purchase at ANVS?
The largest single insider open-market purchase at ANVS in the rolling window was $1.5M by Director Hoffman Michael B on 2026-04-02.
What is the total insider buy and sell value at ANVS in the current window?
Inside the rolling window, insiders at ANVS bought $4.3M and sold $0 based on SEC Form 4 filings.
Can I get alerts for ANVS insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Annovis Bio, Inc. (ANVS). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Annovis Bio, Inc. is in the Healthcare sector.